Xiang lab - Cancer Immunol Immunother paper
CD40 agonist improves the therapeutic efficacy of irreversible electroporation ablation for metastatic melanoma by promoting unexpected CD8+CD103+ cDC1 and TRM cell responses
Xiang lab - Front Immunol paper
The 41BB-agonist potentiates the therapeutic efficacy of a combined irreversible electroporation ablation treatment of lung cancer by promoting unexpected CD8+CD103+ cDC1 and tissue-resident memory T cell responses
Wu lab - Front Immunol paper
Catch me if you can: viral nucleic acids to host sensors
Vizeacoumar lab - Cancer Cell Int paper
The DRP1 receptor FIS1 is critical to the expansion of triple-negative breast cancer tumor-initiating cells
Lukong lab - Front Oncol paper
Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα-positive breast cancer.
Vizeacoumar lab - Cell Genom paper
Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality
Vizeacoumar lab - Oncogene paper
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer
Anderson lab - Biochim Biophys Acta Mol Basis Dis paper
Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells
Lukong lab - Oncol Rev paper
Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.
Xiang lab - Int J Mol Sci paper
Focal Adhesion Kinase Alleviates Simulated Microgravity-Induced Inhibition of Osteoblast Differentiation by Activating Transcriptional Wnt/β-Catenin-BMP2-COL1 and Metabolic SIRT1-PGC-1α-CPT1A Pathways